前收市價 | 0.7912 |
開市 | 0.7800 |
買盤 | 0.7933 x 100 |
賣出價 | 0.7979 x 300 |
今日波幅 | 0.7725 - 0.8179 |
52 週波幅 | 0.6300 - 1.3700 |
成交量 | |
平均成交量 | 1,495,904 |
市值 | 327.175M |
Beta 值 (5 年,每月) | 1.96 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.1300 |
業績公佈日 | 2024年5月01日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 1.00 |
Denali Therapeutics (DNLI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript May 1, 2024 Amarin Corporation plc misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $-0.0075. AMRN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
Here is how Amarin (AMRN) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.